Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

CapEx Revival: Still Waiting

Published 04/20/2014, 12:08 AM
Updated 07/09/2023, 06:31 AM

In a recent post, I wrote that the US economy is mid-cycle and we need to see signs of capital expenditure acceleration for stock prices to meaningfully advance from current levels (see What equity bulls need for the next phase). One of the clues would be the earnings reports from companies in capital goods conglomerates, like General Electric (NYSE:GE).

GE reported on Thursday and Honeywell (NYSE:HON), another capital goods conglomerate, reported on the same day. The best description of my reaction to both reports is, "Meh!"

GE: Flat top-line growth

The GE earnings report was a solid report for shareholders, but I was not looking at it from a shareholder perspective. Rather, I was using it to look for clues about global, or at least American, capex acceleration. The presentation, which can be found here, left me a little wanting. 

In particular, this page, showing the progression of their order backlog was a little disappointing. Backlog growth from 4Q to 1Q was flat, having increased from $23.6 billion to $23.7 billion.

GE Order Backlog
The oil and gas division provided much of the source of capex growth, but that should be no surprise. David Kostin of Goldman Sachs broke out capex by sector and showed that the energy sector had been increasing its share of capex within the S&P 500 for several quarters (via Business Insider). While there were some bright spots in the other GE divisions, there appears to be no broad based capex acceleration on an ex-energy basis.
Capex Spending by Sector

Little sales growth at Honeywell either

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The Honeywell report, which is available here, was also somewhat disappointing. The company beat Street expectations on earnings but missed on sales (remember we are looking for sales acceleration). Sales were up only 1% on an organic basis YoY. The environment in the Defense and Space division was problematic and HON saw good top-line acceleration in Europe from sales of their turbochargers.

The company's expected organic sales growth—my key metric—is 3% in the next quarter and 4% in the 2H2014, ex-Defense and Space. While they did raise earnings guidance, sales guidance was unchanged.

If HON were to be representative of the capex outlook, 3-4% isn't a bad number, but it falls short of a picture of capex acceleration that the Street has been expecting. The same comment would also apply to GE. To top it all off, Bill McBride at Calculated Risk recently highlighted an environment which features a sluggish recovery for US heavy truck sales:

Heavy Truck Sales: January 1967-Present

In short, waiting for a capex revival can still be likened to Waiting for Godot.
 
Disclosure: Cam Hui is a portfolio manager at Qwest Investment Fund Management Ltd. (“Qwest”). The opinions and any recommendations expressed in the blog are those of the author and do not reflect the opinions and recommendations of Qwest. Qwest reviews Mr. Hui’s blog to ensure it is connected with Mr. Hui’s obligation to deal fairly, honestly and in good faith with the blog’s readers.

None of the information or opinions expressed in this blog constitutes a solicitation for the purchase or sale of any security or other instrument. Nothing in this blog constitutes investment advice and any recommendations that may be contained herein have not been based upon a consideration of the investment objectives, financial situation or particular needs of any specific recipient. Any purchase or sale activity in any securities or other instrument should be based upon your own analysis and conclusions. Past performance is not indicative of future results. Either Qwest or I may hold or control long or short positions in the securities or instruments mentioned.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.